Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Silicone Barrier Spray Versus Zinc Oxide Ointment for Incontinence-Associated Dermatitis

NCT: NCT07637695 · COMPLETED

NCT IDNCT07637695
StatusCOMPLETED
Start Date2023-01-01
Completion2023-11-30
SponsorTaoyuan Armed Forces General Hospital (OTHER_GOV)
First posted
Last updated

Brief Summary

Incontinence-associated dermatitis (IAD) is a common skin condition among long-term care residents and is caused by prolonged exposure to urine or feces. IAD can lead to skin irritation, discomfort, impaired skin integrity, and an increased risk of secondary complications. Structured skin care, including cleansing and barrier protection, is recommended for the prevention and management of IAD. This randomized controlled trial evaluated the effectiveness of a silicone barrier spray compared with zinc oxide ointment as part of a structured skin care program for residents with mild IAD in a long-term care facility. Participants were randomly assigned to receive either silicone barrier spray or zinc oxide ointment following routine skin cleansing. Clinical severity of IAD and skin barrier function were assessed at baseline, Day 7, and Day 14 using standardized clinical and biophysical measurements, including IAD severity score, skin hydration, transepidermal water loss, skin pH, and skin temperature. The study aimed to determine whether silicone barrier spray provides comparable or improved outcomes compared with conventional zinc oxide ointment in the management of mild IAD.

Frequently Asked Questions

What is Silicone Barrier Spray Versus Zinc Oxide Ointment for Incontinence-Associated Dermatitis?

Silicone Barrier Spray Versus Zinc Oxide Ointment for Incontinence-Associated Dermatitis is a clinical trial registered under NCT07637695. Current status: COMPLETED.

What is the status of NCT07637695?

The current status of NCT07637695 (Silicone Barrier Spray Versus Zinc Oxide Ointment for Incontinence-Associated Dermatitis) is: COMPLETED.

When did Silicone Barrier Spray Versus Zinc Oxide Ointment for Incontinence-Associated Dermatitis start?

Silicone Barrier Spray Versus Zinc Oxide Ointment for Incontinence-Associated Dermatitis started on 2023-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.